KISS1R and fatty liver disease: Depletion of hepatic Kiss1r exacerbated hepatic steatosis, while the pharmacological enhancement of KISS1R signaling lowered hepatic triglyceride content, serum triglyceride levels, and serum free fatty acid levels [8].